Side Effect Management

Sociodemographic factors affect some survivors who may not have easy access to health care or healthy food, reducing their health-related quality of life.

Michelle Anderson-Benjamin, who received a diagnosis of metastatic breast cancer in 2022, works as a death doula to provide end-of-life support to patients and their families.

An oncology nurse discusses how virtual reality can be used to educate patients and decrease stress before treatment or while in palliative care.

Straying away from standard-of-care chemotherapy can improve quality of life without sacrificing outcomes in older patients with advanced cancer.

“Sleep apnea assessment must be a part of routine risk assessment for patients undergoing cancer therapeutics,” one researcher stated.

Survivors who were more physically active may experience less pain than survivors who were not as physically active, research found.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

A 2.5-mg dose of olanzapine provided similar control of nausea/vomiting as the standard 10-milligram dose in patients with solid tumors receiving chemotherapy.

A digital tool for caregivers of patients with cancer in hospice care significantly reduced some of the caregiver burden while improving their mood.

Slower infusion rates of antiemetic drugs may help manage nausea and vomiting in patients with gastric or gastroesophageal junction cancers.

Some treatment-related cardiovascular events, such as atrial fibrillation, may be more common in patients with non-small cell lung cancer, research shows.

There were certain characteristics associated with a perceived loss of dignity in patients with cancer, according to recent research.

It’s important to know what kinds of treatments are available for bladder cancer and understand that having a “tailored” treatment is important for patients, experts said.

A cancer-related side effect I faced was constipation caused by pain medication.

We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.

Patients recently treated for cancer who required hospitalization for COVID-19 were at risk for venous thromboembolisms (VTEs), recent research has found, with investigators determining that patients who experience a thromboembolic event (TEE) are at a 20% to 25% risk of death.

Recent research determined that two specific biomarkers may help predict and protect survivors of childhood cancer from heart risks, such as cardiomyopathy.

Children with cancer tended to feel less anxiety after undergoing four sessions of creative art therapy, recent research showed.

From Jimmy Buffett's death to the chemo shortage and cannabis use in cancer care, here is a look back at some of our most popular oncology stories from 2023.

The use best use of opioids or NSAIDS may vary based on the type of pain patients with cancer are experiencing, recent research found.

Breast cancer treatment can disrupt patients’ quality and quantity of sleep, leaving them fatigued and restless during the day.

A recent study showed that incorporating immunotherapy checkpoint blockade into treatment before and after surgery can increase treatment-related side effects.

The FDA granted an orphan drug designation for the novel drug, NT-17, to treat people with acute radiation syndrome.

Receiving palliative care is important for adolescent and young adult patients, as they experience a time of identity development, an expert told CURE®.

A phase 3 trial found that testosterone recovery after androgen deprivation therapy leads to better quality of life following high-risk prostate cancer.

Managing side effects from lung cancer treatment with dose reductions is an approach experts have been using more, even though some patients voice concerns about lowering a drug’s impact on the disease.

One expert explains why palliative care for patients with cancer “is about aligning the patient's goals and the family's goals with the therapeutic goals.”

The benefit of neurofeedback by a closed-loop brain-computer interface was prominent when treating chemotherapy-induced peripheral neuropathy in patients with breast cancer.

Adding debulking surgery to chemotherapy did not cause a significant decrease in health-related quality of life for patients with metastatic colorectal cancer, research showed.

More than half of patients may experience PMPS, a type of chronic nerve pain, following mastectomy and breast surgery.